Merck & Co., Inc: Chronic Cough trials

The registry lists 13 Chronic Cough studies with Merck & Co., Inc as lead sponsor. 0 are open to participants now and 13 have results posted.

Phase 2 7Phase 3 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)-China ExtensionCompletedNCT04525885Phase 3Results posted
• Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants With Recent Onset Chronic Cough (MK-7264-043)CompletedNCT04193202Phase 3Results posted
• Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)CompletedNCT04193176Phase 3Results posted
• A Study of Gefapixant (MK-7264) in Japanese Adult Participants With Refractory or Unexplained Chronic Cough (MK-7264-038)CompletedNCT03696108Phase 3Results posted
• Study of Gefapixant (MK-7264) in Adult Japanese Participants With Unexplained or Refractory Chronic Cough (MK-7264-033)CompletedNCT03482713Phase 2Results posted
• A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)CompletedNCT03449147Phase 3Results posted
• A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-027)CompletedNCT03449134Phase 3Results posted
• An 8-Week Refractory Chronic Cough Study (MK-7264-021)CompletedNCT02612623Phase 2Results posted
• A 12-Week Study in Participants With Refractory Chronic Cough (MK-7264-012)CompletedNCT02612610Phase 2Results posted
• Effect of Gefapixant (MK-7264/AF-219) on Cough Reflex Sensitivity in Healthy and Chronic Cough Participants (MK-7264-014)CompletedNCT02476890Phase 2Results posted
• Effect of Gefapixant (AF-219/MK-7264) on Cough Reflex Sensitivity (MK-7264-015)CompletedNCT02397460Phase 2Results posted
• A Dose Escalation Study of Gefapixant (AF-219/MK-7264) in Refractory Chronic Cough (MK-7264-010)CompletedNCT02349425Phase 2Results posted
• A Study to Assess the Efficacy of Gefapixant (MK-7264/AF-219), in Participants With Chronic Cough (MK-7264-006)CompletedNCT01432730Phase 2Results posted